Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Sullivan

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
The Medical Journal of Australia|June 2, 2017
Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiativeSanthi Chalasani, David P Peiris, Tim Usherwood, et al.
Plos One|January 15, 2010
A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trialsJohn Simes, Merryn Voysey, Rachel O'Connell, et al.
Nature Reviews. Cardiology|January 25, 2020
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careGerald F Watts, Samuel S Gidding, Pedro Mata, et al.
Thorax|February 16, 2012
Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover studyCraig L Phillips, Bradley J McEwen, Marie-Christine Morel-Kopp, et al.
Thrombosis and Haemostasis|August 25, 2012
Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover studyBradley J McEwen, Craig L Phillips, Marie-Christine Morel-Kopp, et al.
Clinical Chemistry|April 26, 2008
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatmentGilles Lambert, Nicolas Ancellin, Francesca Charlton, et al.
The Clinical Biochemist. Reviews|February 25, 2012
A model of care for familial hypercholesterolaemia: key role for clinical biochemistryGerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2012
Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational studyGraeme J Hankey, Neil E Anderson, Ru-Dee Ting, et al.
Diabetes Care|December 20, 2014
Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetesMarkus Herrmann, David R Sullivan, Anne-Sophie Veillard, et al.
Heart, Lung & Circulation|May 29, 2012
A new model of care for familial hypercholesterolaemia: what is the role of cardiology?Gerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
The Medical Journal of Australia|June 2, 2017
Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiativeSanthi Chalasani, David P Peiris, Tim Usherwood, et al.
Plos One|January 15, 2010
A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trialsJohn Simes, Merryn Voysey, Rachel O'Connell, et al.
Nature Reviews. Cardiology|January 25, 2020
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careGerald F Watts, Samuel S Gidding, Pedro Mata, et al.
Thorax|February 16, 2012
Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover studyCraig L Phillips, Bradley J McEwen, Marie-Christine Morel-Kopp, et al.
Thrombosis and Haemostasis|August 25, 2012
Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover studyBradley J McEwen, Craig L Phillips, Marie-Christine Morel-Kopp, et al.
Clinical Chemistry|April 26, 2008
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatmentGilles Lambert, Nicolas Ancellin, Francesca Charlton, et al.
The Clinical Biochemist. Reviews|February 25, 2012
A model of care for familial hypercholesterolaemia: key role for clinical biochemistryGerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2012
Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational studyGraeme J Hankey, Neil E Anderson, Ru-Dee Ting, et al.
Diabetes Care|December 20, 2014
Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetesMarkus Herrmann, David R Sullivan, Anne-Sophie Veillard, et al.
Heart, Lung & Circulation|May 29, 2012
A new model of care for familial hypercholesterolaemia: what is the role of cardiology?Gerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
Pageof 11